Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
6,307,855
-
Shares change
-
-395,777
-
Total reported value, excl. options
-
$41,615,000
-
Value change
-
-$2,526,064
-
Number of sells
-
10
-
Price
-
$6.47
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2022
As of 31 Mar 2022 SINOVAC BIOTECH LTD. - Common Shares (SVA) had 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,307,855 shares of stock of the company.
Largest 6 holders included Vivo Capital, LLC, Neumann Advisory Hong Kong Ltd, Yorktown Management & Research Co Inc, Eqis Capital Management, Inc., Financial Gravity Asset Management, Inc., and IFP Advisors, Inc.
This table shows 6 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.